WESTON, Fla., June 2, 2004 (PRIMEZONE) -- Stocks started the day on an upnote Wednesday, with both the Dow and the Nasdaq gapping up at the open. Concerns over the price of crude and trouble in Iraq continued to weigh on investors, stocks seemed set for the green. The Nasdaq Composite was up 4.28 points, to 1,988.43, while the Dow Jones industrial average was higher by 11.42 points, to 10,214.87.
Crude oil futures eased back below $42 per barrel on Wednesday, after several sessions of gaining ground. The price of crude oil rose after the U.S.-appointed head of the Iraqi Governing Council, Ezzedine Salim, was killed last Monday near the U.S. headquarters in Baghdad. Also damaging investor confidence were Commerce Department figures showing the U.S. trade deficit widened by 9.1 percent to a record $46 billion, much higher than what analysts were expecting.
Stocks in the news include Allos Therapeutics (Nasdaq:ALTH) announced today that it has received an 'approvable' letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for RSR13 (efaproxiral) for the treatment of patients with brain metastases originating from breast cancer.
Genta Incorporated (Nasdaq:GNTA) which was trading higher by 18% in early dealings on over 2 million shares. The Company recently announced the termination of the Expanded Access Program (EAP) for Genasense(TM) (oblimersen sodium) Injection in combination with dacarbazine (DTIC) with Aventis (NYSE:AVE).
And Cardima, Inc. (Nasdaq:CRDM) which announced that it has scheduled a meeting with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) on June 18, 2004, in response to the FDA's strong encouragement for Cardima to meet with FDA representatives to discuss how Cardima might most rapidly proceed to address key issues raised in a recent letter from the FDA to Cardima.
The latest Federal Open Market Committee meeting was held on Tuesday, May 4, 2004, where the FOMC changed its tune somewhat, saying in its statement that "The Committee perceives the upside and downside risks to the attainment of sustainable growth for the next few quarters are roughly equal," the FOMC said in its statement. "Similarly, the risks to the goal of price stability have moved into balance. At this juncture, with inflation low and resource use slack, the Committee believes that policy accommodation can be removed at a pace that is likely to be measured."
In plain terms The Fed is saying that conditions have improved to the point that rates can start moving up from their current historically low levels, but will probably do so at a measured, and even pace . . . no 50 and 75 basis point hikes in the near future. The Fed also said it "continues to believe that an accommodative stance of monetary policy, coupled with robust underlying growth in productivity, is providing important ongoing support to economic activity." Regardless, many analysts are saying the first rate increase may come as early as June.
ABOUT TheSUBWAY.com:
TheSUBWAY.com, a leader in corporate communications and finance, provides all investors with a wide-ranging set of financial tools, including original stock market commentary, stock quotes, interactive charts, portfolio watch, live chat and message boards, etc., plus the latest news, press releases, and research reports for all companies highlighted on the site. For more, please visit http://www.thesubway.com/sub_comm.asp.